Functional Neuroimaging in Fibromyalgia Patients Receiving tDCS
Unknown statusPhase 2NCT01904097
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to evaluate effectiveness and cerebral neuronal ability to adaptation in patients with fibromyalgia who receive pregabalin and transcranial direct current stimulation.
Study details
- Official title
- Study of the Brain With Optic Functional Neuroimaging in Patients With Chronic Pain Using Transcranial Direct Current Stimulation
- Conditions
- Interventions
- Drug: Pregabalin
- Other: Transcranial Direct Current Stimulation
- Other: Sham Transcranial Direct Current Stimulation
- Sponsor
- Hospital de Clinicas de Porto Alegre
- Start date
- 2013-03
- Primary completion
- 2014-07
- Sex
- Female
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Brazil
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * \- Diagnosis of fibromyalgia according to the American College of Rheumatology criteria Exclusion Criteria: * Psychiatric or neurologic disorder that unable patient to consent and follow study protocol. * De-compensated systemic disease. * Chronic inflammatory disease (e.g. Systemic Lupus Erythematous, Rheumatoid Arthritis).
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01904097